MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517062694 A) filed by The Board Of Trustees Of The Leland Stanford Junior University, Stanford, U.S.A., on July 1, for 'injectable formulation comprising a biopharmaceutical agent and a polyacrylamide-based copolymer.'
Inventor(s) include Appel, Eric A.; Jons, Carolyn; and Prossnitz, Alex.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure provides injectable pharmaceutical compositions including suspended particles in a liquid carrier, where the particles of the composition include a biopharmaceutical agent and a polyacrylamide-based copolymer. The inventors have demonstrated that particular polyacrylamide-based copolymers can be used as stabilizing excipients in particle formulations of biopharmaceutical agents, without interacting directly with the biopharmaceutical agent, or altering its pharmacokinetic properties. The pharmaceutical composition can be formulated for injection to a patient. Also provided is a syringe loaded with the injectable pharmaceutical composition, methods of administering via injection a therapeutically effective dose of a biopharmaceutical to a subject in need thereof, and methods of preparing a subject injectable pharmaceutical composition."
The patent application was internationally filed on Jan. 05, 2024, under International application No.PCT/US2024/010557.
Disclaimer: Curated by HT Syndication.
